Risk of Alloimmunization and Delayed Hemolytic Transfusion Reactions in Patients With Sickle Cell Disease

Archives of Internal Medicine

Volumn 148, Issue 11, 1988, Pages 2485-2489

  Cox, John V ^a   Steane, Edwin ^a   Cunningham, Gary ^a   Frenkel, Eugene P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; BLOOD TRANSFUSION; CONTROLLED STUDY; DELAYED HEMOLYTIC TRANSFUSION REACTION; FEMALE; HUMAN; MALE; METHODOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SICKLE CELL ANEMIA;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPS; BLOOD TRANSFUSION; CASE REPORT; ERYTHROCYTES; FEMALE; HUMAN; ISOANTIBODIES; KELL BLOOD-GROUP SYSTEM; MALE; RH-HR BLOOD-GROUP SYSTEM; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0023743090     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1988.00380110115024     Document Type: Article

References (27)

1. 1. Charache S: The treatment of sickle cell anemia. Arch Intern Med 1974;133:698-704.
2. 2. Cunningham FG, Pritchard JA: Prophylactic transfusion of normal red blood cells during pregnancies complicated by sickle cell hemoglobinopathies. Am J Obstet Gynecol 1980;135:994-1003.
3. 3. Cunningham FG, Pritchard JA, Mason R: Pregnancy and sickle cell hemoglobinopathies: Results with and without prophylactic transfusions. Obstet Gynecol 1983;62:419-424.
4. 4. Morrison JC, Wiser WL: The use of prophylactic partial exchange transfusion in pregnancies associated with sickle cell hemoglobinopathies. Obstet Gynecol 1976;48:516.
5. 5. Wilimas J, Goff JR, Anderson HR Jr, et al: Effect of transfusion therapy for one to two years on patients with sickle cell disease and cerebrovascular accidents. J Pediatr 1980;96:205-208.
6. 6. Russell MO, Goldberg HI, Hodson A, et al: Effect of transfusion therapy on arteriographic abnormalities and on recurrences of stroke in sickle cell disease. Blood 1984;63:162-169.
7. 7. Kleinman S, Thompson-Breton R, Breen D, et al: Exchange red cell pheresis in a pediatric patient with severe complications of sickle cell anemia. Transfusion 1981;21:443-446.
8. 8. Rifkind S, Waisman J, Thompson R, et al: RBC exchange pheresis for priapism in sickle cell disease. JAMA 1979;242:2317-2318.
9. 9. Coker NJ, Milner PF: Elective surgery in patients with sickle cell anemia. Arch Otolaryngol Head Neck Surg 1982;108:574-576.
10. 10. Keidan AJ, Marwah SS, Vaughn GR, et al: Painful sickle cell crises precipitated by stopping prophylactic exchange transfusions. J Clin Pathol 1987;40:505-507.
11. 11. Brody JI, Goldsmith MH, Park SK, et al: Symptomatic crises of sickle cell anemia treated by limited exchange transfusion. Ann Intern Med 1970;72:327-330.
12. 12. Mayer K (ed): Guidelines to Transfusion Practices. Washington, DC, American Association of Blood Banks, 1980, pp 41-47.
13. 13. Petz LD, Swisher SN, Branch DR: Red cell compatibility testing, in Petz LD, Swisher SN (eds): Clinical Practice of Blood Transfusion. New York, Churchill Livingstone Inc, 1981, pp 169-197.
14. 14. Mollison PL: Blood Transfusion in Clinical Medicine, ed 7. Boston, Blackwell Scientific Publications Inc, 1983, pp 220-223.
15. 15. Diamond WJ, Brown FL, Bitterman P, et al: Delayed hemolytic transfusion reaction presenting as sickle cell crisis. Ann Intern Med 1980;93:231-233.
16. 16. Milner PF, Squires JE, Larism PJ, et al: Posttransfusion crises in sickle cell anemia: Role of delayed hemolytic reactions to transfusion. South Med J 1985;78:1462-1469.
17. 17. Orlina AR, Unger PJ, Kosky M: Post-transfusion alloimmunization in patients with sickle cell disease. Am J Hematol 1978;5:101-106.
18. 18. Coles SM, Klein HG, Holland PV: Alloimmunization in two multitransfused patient populations. Transfusion 1981;21:462-466.
19. 19. Davies SC, McWilliam AC, Hewitt PE, et al: Red cell alloimmunization in sickle cell disease. Br J Hematol 1986;63:241-245.
20. 20. Pineda AA, Brzica SM, Taswell HF: Hemolytic transfusion reaction: Recent experience in a large blood bank. Mayo Clin Proc 1978;53:378-390.
21. 21. Sarnaik S, Schormack J, Lusher JM: The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion 1986;26:249-252.
22. 22. Ambruso DR, Githens JH, Alcorn R, et al: Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987;27:94-98.
23. 23. Giblett ER: A critique of the theoretical hazard of inter vs intraracial transfusion. Transfusion 1961;1:233-238.
24. 24. Lostumbo MM, Holland PV, Schmidt PJ: Isoimmunization after multiple transfusions. N Engl J Med 1966;275:141-144.
25. 25. Blumberg N, Ross K, Avila E, et al: Should chronic transfusion be matched for antigens other than ABO and Rho(D)? Vox Sang 1984;47: 205-208.
26. 26. Domen RE, Ramirez G, Clalero A: Red cell alloimmunization in chronic renal disease patients, abstracted. Blood 1986;68(suppl 1):296a.
27. 27. Pineda AA, Taswell HF, Brzica SM: Delayed hemolytic transfusion reaction: An immunologic hazard of blood transfusion. Transfusion 1978;18:1-6.